aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.
Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a hybrid distribution strategy via distribution agents and partnerships with global orthopaedic and medical technology companies.
In North America, aap’s 3Q15 sales to local distributors and global partners grew to ~$0.75MM, up from ~$0.11MM in 3Q15.
aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.
Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a...
aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.
Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a hybrid distribution strategy via distribution agents and partnerships with global orthopaedic and medical technology companies.
In North America, aap’s 3Q15 sales to local distributors and global partners grew to ~$0.75MM, up from ~$0.11MM in 3Q15.
Copy to clipboard 
